ALLIANCEBERNSTEIN L.P.

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 1109448 NASHVILLE, TN

Position in AMLX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,123,120

+$259,400 QoQ

Shares Held

80,800

+13.0% QoQ

Ownership

0.073%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2022

12 quarters on record

Voting authority Sole 92% Shared 0% None 8%

Healthcare · as of Mar 31, 2026

ALLIANCEBERNSTEIN L.P. holds $800,528,984 across 41 Drug Manufacturers - Specialty & Generic names. AMLX ranks #22 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	3,633,318	$429,494,520
2	UTHR	UNITED THERAPEUTICS Corp	220,634	$130,831,549
3	NBIX	Neurocrine Biosciences Inc	523,533	$68,970,237
4	RDY	Dr Reddys Laboratories Ltd	2,541,889	$35,205,162
5	KNSA	Kiniksa Pharmaceuticals International, plc	598,888	$28,836,457
6	VTRS	Viatris Inc	1,229,714	$16,613,436
7	ELAN	Elanco Animal Health Inc	624,049	$14,933,492
8	HIMS	Hims & Hers Health, Inc.	501,138	$10,403,624

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,123,120	80,800	+13.0%	Shares	Defined	2026-05-15
2025-12-31	$863,720	71,500	0.0%	Shares	Defined	2026-02-17
2025-09-30	$971,685	71,500	+133.7%	Shares	Defined	2025-11-14
2025-06-30	$196,146	30,600	-40.6%	Shares	Defined	2025-08-14
2024-03-31	$146,379	51,542	0.0%	Shares	Defined	2024-05-14
2023-12-31	$758,698	51,542	0.0%	Shares	Defined	2024-02-14
2023-09-30	$943,734	51,542	0.0%	Shares	Defined	2023-11-14
2023-06-30	$1,111,760	51,542	0.0%	Shares	Defined	2023-08-15
2023-03-31	$1,512,242	51,542	+42.2%	Shares	Defined	2023-05-15
2022-12-31	$1,339,141	36,242	0.0%	Shares	Defined	2023-02-15
2022-09-30	$1,020,212	36,242	+1.0%	Shares	Defined	2022-11-15
2022-06-30	$691,434	35,900	—	Shares	Defined	2022-08-15
No filing history on record for this holder in this stock.